Labcorp Q4 Revenue Misses by $50M Despite $4.07 EPS Beat, Shares Drop
Labcorp’s Q4 revenue of $3.52 billion missed analysts’ $3.57 billion consensus while adjusted EPS rose to $4.07, above the $3.94 estimate. 2026 revenue guidance was in line with forecasts and EPS outlook slightly above expectations, but shares fell 2.7% on the top-line miss.
1. Q4 Earnings and Revenue Miss
Labcorp reported Q4 revenue of $3.52 billion, trailing the $3.57 billion consensus, though sales still rose 5.6% year-over-year. Adjusted EPS reached $4.07, topping the $3.94 estimate.
2. 2026 Guidance Details
For 2026, the company set revenue guidance aligned with analyst forecasts and projected adjusted EPS slightly above market expectations. The outlook reflects consistent demand across diagnostics and biopharma segments.
3. Share Reaction and Performance Context
Shares declined 2.7% following the revenue miss despite the EPS beat and solid outlook. The stock is up 9.7% year-to-date, trading at $276.02 per share, close to its 52-week high of $290.93.